Japan Gene Therapies Progress In Post-Zolgensma World
Otsuka, Others Move Forward In Supportive Environment
The recent reimbursement and launch of Zolgensma showed Japan willing and able to approve and pay for gene therapies, and others including from Otsuka/Takara Bio are moving forward under a supportive regulatory framework.
